Examples of tumor types where the molecular features provided additional information include cholangiocarcinoma (IDH1 R132C and BAP1 splice site), colorectal cancer (MSI-High with BRAF V600E mutation), and non-small-cell lung cancer (KRAS G12D and STK11 frameshift mutation). This evidence concerns the gene KRAS and non-small cell lung carcinoma.